Loading…
Loading…
BBOT (BridgeBio Oncology Therapeutics Inc.) is a recent IPO.
It began trading on August 12, 2025, giving it less than a year of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.
| TNGX | Tango Therapeutics, Inc. | $29.02 | $3.6B |
| ANAB | AnaptysBio, Inc. | $53.76 | $2.3B |
| KOD | Kodiak Sciences Inc. | $42.42 | $2.2B |
| URGN | UroGen Pharma Ltd. | $43.78 | $2.1B |
| NRIX | Nurix Therapeutics, Inc. | $23.48 | $2.0B |
| MNMD | Mind Medicine (MindMed) Inc. | $20.69 | $1.6B |
| SEPN | Septerna Inc | $33.68 | $1.5B |
| XNCR | Xencor, Inc. | $20.45 | $1.5B |
| PHAT | Phathom Pharmaceuticals, Inc. | $11.25 | $897.3M |
| OCS | Oculis Holding AG | $11.96 | $683.7M |